Completion and Discontinuation Rates According to Parity Status and Age.

All p values were calculated using Fisher’s exact tests. Only statistically significant p values (p * Women who discontinued owing to change in menstrual bleeding pattern (including amenorrhoea) are a subset of those who discontinued owing to AEs.† Non-AE-related reasons for premature discontinuation included withdrawal of consent, protocol deviation, death, subject was lost to follow-up, pregnancy, desire for pregnancy and ‘other’ reason.‡ Women who discontinued due to desire for pregnancy were a subset of those who discontinued due to non-AE-related reasons.AE, adverse event; LNG-IUS 8; levonorgestrel intrauterine system total content 13.5 mg (average approx. 8 μg/24 hours over the first year); LNG-IUS 13, levonorgestrel intrauterine system total content 19.5 mg (average approx. 13 μg/24 hours over the first year).Completion and Discontinuation Rates According to Parity Status and Age.